Roger Song
Stock Analyst at Jefferies
(2.90)
# 2,732
Out of 5,090 analysts
273
Total ratings
39.9%
Success rate
1.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABCL AbCellera Biologics | Initiated Coverage: Buy | $21 | $12.27 | +71.15% | 1 | Oct 30, 2026 | |
| ARTV Artiva Biotherapeutics | Downgraded: Hold | $4 | $4.19 | -4.53% | 1 | Oct 28, 2026 | |
| REPL Replimune Group | Rated: Buy | $24 → $29 | $17.61 | +64.68% | 17 | Oct 28, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | $146 | $62.03 | +135.37% | 9 | Oct 5, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | $121 → $150 | $38.87 | +285.90% | 12 | Oct 1, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $704 | $598.72 | +17.58% | 18 | Oct 1, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $101 | $27.28 | +270.23% | 13 | Sep 23, 2026 | |
| GPCR Structure Therapeutics | Reiterated: Buy | $125 | $21.87 | +471.56% | 19 | Sep 8, 2026 | |
| MANE Veradermics | Reiterated: Buy | $182 | $139.69 | +30.29% | 6 | Sep 8, 2026 | |
| KLRA Kailera Therapeutics | Reiterated: Buy | $48 | $12.86 | +273.25% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $25.63 | +102.89% | 2 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1.8 → $3 | $0.6024 | +398.01% | 4 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $133 | $96.87 | +37.30% | 4 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $21 | $5.87 | +257.75% | 7 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 | $61.18 | +35.67% | 6 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $371 → $474 | $332.29 | +42.65% | 3 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $26.80 | +67.91% | 6 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $3.35 | +228.36% | 1 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $2.08 | +92.31% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $71 | $92.24 | -23.03% | 6 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.18 | +747.46% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $18 | $3.59 | +401.39% | 4 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.51 | +827.15% | 3 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $16 | $2.34 | +583.76% | 5 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $42 | $10.03 | +318.74% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $154 | $80.84 | +90.50% | 6 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $10.26 | +172.90% | 20 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $4.56 | n/a | 1 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $40 | $9.10 | n/a | 3 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.6395 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $17 | $4.94 | n/a | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $4 | $1.37 | n/a | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $55.87 | n/a | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $2.04 | n/a | 16 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $0.43 | n/a | 4 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.97 | n/a | 13 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $144.85 | n/a | 6 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.7065 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $18 | $1.66 | n/a | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $2.57 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.0001 | n/a | 4 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $28.39 | n/a | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $25 | $10.08 | n/a | 16 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $1.5 | $3.24 | n/a | 6 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $13.48 | n/a | 5 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $68 | $30.10 | n/a | 2 | Nov 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $3.88 | n/a | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $146.15 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $0.7928 | n/a | 1 | Apr 29, 2021 |
AbCellera Biologics
Oct 30, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $12.27
Upside: +71.15%
Artiva Biotherapeutics
Oct 28, 2026
Downgraded: Hold
Price Target: $4
Current: $4.19
Upside: -4.53%
Replimune Group
Oct 28, 2026
Rated: Buy
Price Target: $24 → $29
Current: $17.61
Upside: +64.68%
Vaxcyte
Oct 5, 2026
Reiterated: Buy
Price Target: $146
Current: $62.03
Upside: +135.37%
Nektar Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $121 → $150
Current: $38.87
Upside: +285.90%
United Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $704
Current: $598.72
Upside: +17.58%
Viking Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $101
Current: $27.28
Upside: +270.23%
Structure Therapeutics
Sep 8, 2026
Reiterated: Buy
Price Target: $125
Current: $21.87
Upside: +471.56%
Veradermics
Sep 8, 2026
Reiterated: Buy
Price Target: $182
Current: $139.69
Upside: +30.29%
Kailera Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $48
Current: $12.86
Upside: +273.25%
Aug 13, 2026
Reiterated: Buy
Price Target: $52
Current: $25.63
Upside: +102.89%
Aug 12, 2026
Upgraded: Buy
Price Target: $1.8 → $3
Current: $0.6024
Upside: +398.01%
Aug 11, 2026
Reiterated: Buy
Price Target: $45 → $133
Current: $96.87
Upside: +37.30%
Jul 31, 2026
Reiterated: Buy
Price Target: $62 → $21
Current: $5.87
Upside: +257.75%
Jul 14, 2026
Reiterated: Buy
Price Target: $83
Current: $61.18
Upside: +35.67%
Jul 13, 2026
Rated: Buy
Price Target: $371 → $474
Current: $332.29
Upside: +42.65%
Jul 8, 2026
Reiterated: Buy
Price Target: $45
Current: $26.80
Upside: +67.91%
May 20, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $3.35
Upside: +228.36%
May 19, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $2.08
Upside: +92.31%
Apr 28, 2026
Reiterated: Buy
Price Target: $58 → $71
Current: $92.24
Upside: -23.03%
Apr 15, 2026
Reiterated: Buy
Price Target: $10
Current: $1.18
Upside: +747.46%
Mar 26, 2026
Rated: Buy
Price Target: $26 → $18
Current: $3.59
Upside: +401.39%
Mar 23, 2026
Reiterated: Buy
Price Target: $14
Current: $1.51
Upside: +827.15%
Mar 18, 2026
Reiterated: Buy
Price Target: $8 → $16
Current: $2.34
Upside: +583.76%
Jan 22, 2026
Reiterated: Buy
Price Target: $13 → $42
Current: $10.03
Upside: +318.74%
Dec 19, 2025
Reiterated: Buy
Price Target: $154
Current: $80.84
Upside: +90.50%
Dec 10, 2025
Reiterated: Buy
Price Target: $28
Current: $10.26
Upside: +172.90%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $4.56
Upside: n/a
Sep 9, 2025
Reiterated: Buy
Price Target: $80 → $40
Current: $9.10
Upside: n/a
Aug 28, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $0.6395
Upside: n/a
Aug 22, 2025
Reiterated: Buy
Price Target: $9 → $17
Current: $4.94
Upside: n/a
Aug 20, 2025
Reiterated: Buy
Price Target: $12 → $4
Current: $1.37
Upside: n/a
Aug 15, 2025
Initiated Coverage: Buy
Price Target: $36
Current: $55.87
Upside: n/a
Jun 26, 2025
Reiterated: Buy
Price Target: $28
Current: $2.04
Upside: n/a
Jun 11, 2025
Reiterated: Buy
Price Target: $10 → $8
Current: $0.43
Upside: n/a
Apr 24, 2025
Reiterated: Buy
Price Target: $7
Current: $3.97
Upside: n/a
Apr 10, 2025
Reiterated: Buy
Price Target: $68
Current: $144.85
Upside: n/a
Apr 1, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $0.7065
Upside: n/a
Mar 26, 2025
Rated: Buy
Price Target: $12 → $18
Current: $1.66
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: $7
Current: $2.57
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $8
Current: $0.0001
Upside: n/a
Jan 10, 2025
Rated: Buy
Price Target: $35
Current: $28.39
Upside: n/a
Oct 16, 2024
Reiterated: Buy
Price Target: $31 → $25
Current: $10.08
Upside: n/a
Aug 21, 2024
Downgraded: Hold
Price Target: $14 → $1.5
Current: $3.24
Upside: n/a
Mar 27, 2024
Reiterated: Buy
Price Target: $5 → $3
Current: $13.48
Upside: n/a
Nov 5, 2023
Rated: Buy
Price Target: $68
Current: $30.10
Upside: n/a
Jul 29, 2022
Initiated Coverage: Buy
Price Target: $9
Current: $3.88
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $6
Current: $146.15
Upside: n/a
Apr 29, 2021
Reiterated: Buy
Price Target: $23
Current: $0.7928
Upside: n/a